Skip to main content
Log in

Thalassemia and related hemoglobinopathies

  • Symposium on Fest - Schrift for Late Dr. P.M. Udani
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Hemoglobinopathies are the most common single gene disorders in man. There are several hundred of these disorders though the thalassemias — alpha and beta and the sickling disorders make up the vast majority. Recent advances in the understanding of the hemoglobin structure and the genetics of its synthesis has contributed significantly to the understanding of these diseases. Disorders include those with reduced globin synthesis, abnormal globin chains and failure to switch globin chain synthesis at the appropriate age. This review focuses on the clinical features, diagnosis and management strategies of the alpha and beta thalassemias, the sickling disorders and touches on a few rarer hemoglobinopathies. It also emphasizes prevention strategies and chronic transfusion safety in countries like India where there are limited resources

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bobhate SK, Gaikwad ST, Bhaledrao T. NESTROFF as a screening test for detection of P-thalassemia trait.Indian J Pathol Microbiol 2002; 45: 265–267.

    CAS  PubMed  Google Scholar 

  2. Mehta BC. NESTROFT: a screening test for β-thalassemia trait.Indian J Med Sci 2002; 56: 537–545

    CAS  PubMed  Google Scholar 

  3. Franchini M, Veneri D. Iron-chelation therapy: an update.Hematol J 2004; 5: 287–292.

    Article  CAS  PubMed  Google Scholar 

  4. Olivieri NF, Brittenham GM, McLaren CEet al. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.N Engl J Med 1998; 339: 417–423.

    Article  CAS  PubMed  Google Scholar 

  5. Wanless IR, Sweeney G, Dhillon APet al. Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent P-thalassemia.Blood 2002; 100: 1566–1569.

    Article  CAS  PubMed  Google Scholar 

  6. Singh H, Pradhan M, Singh RLet al. High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions.Vox Sang 2003; 84: 292–929.

    Article  CAS  PubMed  Google Scholar 

  7. Marwaha RK, Bansal D, Sharma Set al. Seroprevalence of hepatitis C and B virus in multiply transfused beta-thalassemics: results from a thalassemic day care unit in north India.Vox Sang 2003; 85: 119–120.

    Article  CAS  PubMed  Google Scholar 

  8. Nishioka. Transfusion transmitted hepatitis B and C.Vox Sang 1996; 70.

  9. Singh B, Verma M, Verma K Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.Jpn J Infect Dis 2004; 57: 49–51.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sharada A. Sarnaik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarnaik, S.A. Thalassemia and related hemoglobinopathies. Indian J Pediatr 72, 319–324 (2005). https://doi.org/10.1007/BF02724015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02724015

Key words

Navigation